Quarterly Outlook
Macro Outlook: The US rate cut cycle has begun
Peter Garnry
Chief Investment Strategist
Summary: Hawkish macro narrative got a further push with hot US ISM services PMI and Fedspeak, but Nvidia rose to a record high. Broader equities, however, were hurt by the relentless rise in yields. Earnings focus today on Eli Lilly, which is turning out to be a key competitor for Novo Nordisk in the obesity drugs space. China markets remained under pressure despite authorities trying to put a floor. US dollar rose to fresh near 3-month highs, and AUD in focus today as RBA decision is on the radar.
The Saxo Quick Take is a short, distilled opinion on financial markets with references to key news and events.
US Equities: A sharp two consecutive day rise in Treasury yields weighed negatively on stocks, seeing the S&P 500 Index and the Nasdaq 100 Index pulling back by 0.2% and 0.3% respectively. Meanwhile, Nvidia rose to a record high of $693 following a bullish report from an analyst at a leading US investment bank. ON Semiconductor surged 9.5% after reporting earnings beating estimates. Estee Lauder jumped 12.2% on a layoff plan to cut costs. In extended trading, Palantir Technologies surged nearly 20% on an upbeat full-year revenue and earnings guidance and management remarks that commercial demand for large-language models “continues to be unrelenting.” For a preview of Eli Lilly’s Q4 results scheduled to be released before the US market opens today, read Peter Garnry’s article here.
Fixed income: Treasuries sold off following Powell’s CBS 60 Minutes interview and extended losses after a hot ISM Services report showing stronger than expected gains in the headline as well as the employment and prices paid components. The 10-year yield surged 14bps to 4.16% and the 2-year added 11bps to yield 4.47%. On Tuesday, the Treasury is auctioning $52 billion in 3-year notes. In this article, Althea Spinozzi, Head of Fixed Income Strategy of Saxo, details a discussion of the upcoming Treasury supply this week.
China/HK Equities: The Hang Seng Index remained weak, edging down 0.2% on Monday. The CSI 300 Index had a 0.7% gain amid support from government-controlled investment funds which masked the brutal selloff of the vast majority of A shares. Out of the 5,343 A-share stocks, 4,898 declined and the Shanghai Composite Index fell by 1% while the CSI Small Cap 500 Index and the CSI 1000 Index plummeted by 2.3% and 6.2% respectively. Over the weekend, Trump's statement on a Fox News interview, threatening tariffs on China exceeding 60%, further impacted the already weak market sentiments. Additionally, on Monday, the Caixin China Services PMI disappointed, falling to 52.7, below expectations. The CSRC issued several statements during the day and in the evening to pledge the maintenance of market stability and warn against “malicious” short selling.
FX: The stronger US ISM services print further added fuel to the recent narrative on a pushback to rate cut expectations, adding to the case for a dollar rally. DXY index traded to highs of 104.60, with EURUSD sliding below 1.0750 and ECB’s inflation expectations will be in focus today. Yen weakness was more measured as USDJPY traded above 148.50 where intervention threat could pick up. NZDUSD also was relatively stable, just as we noted in our Weekly FX Chartbook yesterday and slide below 0.6050 found some buyers. AUDUSD however broke below 0.65 and RBA meeting is in focus today. Any pushback to dovish expectations could spark a recovery in AUD, but a broader bearish trend is likely to stay. AUDNZD is on its wat to test the 1.07 handle again after failing at that level last week.
Commodities: Crude oil prices registered modest gains on Monday despite a hawkish macro narrative gripping market, as geopolitical angst continued. Oil, however, remains range-bound amid no supply disruptions seen. Gold prices slid further to break below 50DMA, currently trading at $2,025 with next support at $2,010 in focus. Silver also extended its decline after failing at trendline resistance last week. Industrial metals were the worst performers of the day amid continued downbeat China rhetoric, but our weekly COT report highlights a cut in short Copper positions.
Macro:
Macro events: UK BRC Retail Sales (Jan), Germany Industrial Orders (Dec), ECB Consumer Expectations Survey (Dec), EZ Retail Sales (Dec), RBA Policy Announcement, Fed’s Mester, Harker, Kashkari, Collins
Earnings: Eli Lilly, Amgen, Gilead, Linde, KKR, UBS, BP, Fiserv, Toyota, Mitsubishi Corp, Nintendo, Intesa Sanpaolo, SMIC, Hua Hong Semiconductor.
In the news:
For all macro, earnings, and dividend events check Saxo’s calendar.
For a global look at markets – go to Inspiration.
Disclaimer
The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)